---
title: "NEXGEL To Report First Quarter 2026 Financial Results on May 15th | NXGL Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286118473.md"
description: "NEXGEL, Inc. (NASDAQ: NXGL) will report its first quarter 2026 financial results on May 15, 2026, and host a conference call at 12:00 P.M. ET. The call will be accessible via U.S. and international numbers, with a replay available until May 29, 2026. NEXGEL specializes in healthcare and beauty products, particularly high-water-content hydrogel products. The company has been in the industry for over two decades and has established strategic partnerships with leading consumer healthcare companies."
datetime: "2026-05-12T06:27:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286118473.md)
  - [en](https://longbridge.com/en/news/286118473.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286118473.md)
---

# NEXGEL To Report First Quarter 2026 Financial Results on May 15th | NXGL Stock News

_Management Will Host a Conference Call at 12:00 P.M. ET on the Same Day_

**LANGHORNE, Pa., May 12, 2026 (GLOBE NEWSWIRE) --** NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced it will report its financial results for the first quarter 2026 ended March 31, 2026, on Friday, May 15, 2026. Following the release of its financial results, the Company will host a conference call at 12:00 P.M. ET on the same day.

**First Quarter 2026 Financial Results Conference Call:**  
**Date**: May 15, 2026  
**Time**: 12:00 P.M. ET  
**Live Call**: 1-800-267-6316 (U.S. Toll Free) or 1-203-518-9783 (International)  
**Webcast**: Events and Presentations

For interested individuals unable to join the conference call, a replay will be available through May 29, 2026, by dialing 1-844-512-2921 (U.S. Toll Free) or 1-412-317-6671 (International). Participants must use the following code to access the replay of the call: 11161819. An archived version of the webcast will also be available for 90 days.

**About NEXGEL, Inc.**  
NEXGEL is a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications. Based in Langhorne, Pa., the Company has developed and manufactured electron-beam, cross-linked hydrogels for over two decades. NEXGEL brands include SilverSeal®, Hexagels®, Turfguard®, Kenkoderm® and Silly George®. Additionally, NEXGEL has strategic contract manufacturing relationships with leading consumer healthcare companies.

**Investor Contact:**  
Valter Pinto, Managing Director  
KCSA Strategic Communications  
212.896.1254  
Nexgel@KCSA.com

### Related Stocks

- [NXGL.US](https://longbridge.com/en/quote/NXGL.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [XHE.US](https://longbridge.com/en/quote/XHE.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [IHI.US](https://longbridge.com/en/quote/IHI.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [NXGLW.US](https://longbridge.com/en/quote/NXGLW.US.md)

## Related News & Research

- [Full Transcript: Cellectar Biosciences Q1 2026 Earnings Call](https://longbridge.com/en/news/286422585.md)
- [Microbot Medical Launches Full Commercial LIBERTY System Rollout](https://longbridge.com/en/news/286423065.md)
- [Lifeward Delays Quarterly Report Amid Deal Accounting](https://longbridge.com/en/news/286586728.md)
- [Resona Asset Management Co. Ltd. Cuts Position in Danaher Corporation $DHR](https://longbridge.com/en/news/286897088.md)
- [Radnor Capital Management LLC Has $1.65 Million Stock Holdings in West Pharmaceutical Services, Inc. $WST](https://longbridge.com/en/news/286893528.md)